Latest News
Conference Coverage
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Patients with immunomodulated inflammatory diseases are not an at-risk group for breakthrough COVID-19 infections, apart from those on anti-CD20...
Conference Coverage
Methotrexate enhances pegloticase response in uncontrolled gout
Greater efficacy and fewer infusion reactions seen with methotrexate-pegloticase combination than pegloticase alone in the placebo-controlled...
From the Journals
Cannabis may relieve pain as effectively as opioids, but more research is needed
Synthetic products with high THC:CBD ratios were associated with moderate improvements in pain.
Conference Coverage
Think it’s ILD? Tell it to the machines
Conference Coverage
First evidence of disease modification with methotrexate in pre-RA
Short-term methotrexate used in patients with arthralgia sustainably reduces disease burden and MRI-detected inflammation in all at-risk groups,...
Feature
Surgeons, who see it up close, offer ways to stop gun violence
A committee of the American College of Surgeons developed specific recommendations in 2018, which are still valid today.
Feature
Lupus mutation may unlock targeted drugs for patient subset
A new study provides definitive proof of one pathway that contributes to lupus, though it’s unclear how many patients with lupus are affected by...
Conference Coverage
High maternal, fetal morbidity rates in SLE pregnancies
Despite steady declines in maternal and fetal mortality among pregnant women with systemic lupus erythematosus, maternal and fetal morbidities...
Guidelines
EULAR recommends starting methotrexate and glucocorticoids in RA management
Contrary to ACR guidance, EULAR recommends starting methotrexate and glucocorticoids but dose reduction and discontinuation is emphasized.
Feature
Woman who faked cancer gets 5 years in prison
Conference Coverage
Dogs can be protective, even against Crohn’s disease